Hantavirus infection cost-effectiveness of therapy

Hantavirus infection Microchapters
Home
Patient Information Hantavirus cardiopulmonary syndrome (HCPS) (patient information) Hemorrhagic fever with renal syndrome (HFRS) (patient information)
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hantavirus infection from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT Scan
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future Investigational Therapies
Case Studies
Case #1
Hantavirus infection cost-effectiveness of therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hantavirus infection cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hantavirus infection cost-effectiveness of therapy
CDC on Hantavirus infection cost-effectiveness of therapy
Hantavirus infection cost-effectiveness of therapy in the news
Blogs on Hantavirus infection cost-effectiveness of therapy
Directions to Hospitals Treating Hantavirus pulmonary syndrome
Risk calculators and risk factors for Hantavirus infection cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]